Insulin infusion protocols for critically ill patients: A highlight of differences and similarities

Endocrine Practice

Volumn 13, Issue 2, 2007, Pages 137-146

  Nazer, Lama H ^a   Chow, Sheryl L ^b,c   Moghissi, Etie S ^c,d  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^b Glendale Memorial Hospital and Health Center   (United States)

^c Centinela Freeman Regional Medical Center   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ARTICLE; BIBLIOGRAPHIC DATABASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CRITICAL ILLNESS; HUMAN; HYPOGLYCEMIA; INSULIN INFUSION; MEDLINE; META ANALYSIS;

CONTROLLED CLINICAL TRIALS; CRITICAL ILLNESS; DATABASES, BIBLIOGRAPHIC; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MEDLINE;

EID: 34447338072     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.13.2.137     Document Type: Article

References (47)

1. Lewis KS, Kane-Gill SL, Bobek MB, Dasta JF. Intensive insulin therapy for critically ill patients. Ann Pharmacother. 2004;38:1243-1251.
2. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-1367.
3. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract. 2004;10(Suppl 2):21-33.
4. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients [erratum in Mayo Clin Proc. 2005;80:1101]. Mayo Clin Proc. 2004;79:992-1000.
5. Grey NJ, Perdrizet GA. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract. 2004;10(Suppl 2):46-52.
6. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effect on mortality at 1 year. J Am Coll Cardiol. 1995;26:57-65.
7. Malmberg K (DIGAMI [Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction] Study Group). Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ. 1997;314:1512-1515.
8. Clement S, Braithwaite SS, Magee MF, et al (American Diabetes Association Diabetes in Hospitals Writing Committee). Management of diabetes and hyperglycemia in hospitals [errata in Diabetes Care. 2004;27:856 and Diabetes Care. 2004;27:1255]. Diabetes Care. 2004;27:553-591.
9. Malmberg K, Ryden L, Wedel H, et al (DIGAMI 2 Investigators). Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005;26:650-661.
10. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449-461.
11. van der Horst IC, Zijlstra F, van't Hof AW, et al (Zwolle Infarct Study Group). Glucose-insulin-potassium infusion in patients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin- potassium study; a randomized trial. J Am Coll Cardiol. 2003;42:784-791.
12. CREATE-ECLA Trial Group Investigators. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA. 2005;293:437-446.
13. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA. 2003;290:2041-2047.
14. Rady MY, Johnson DJ, Patel BM, Larson JS, Helmers RA. Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus. Mayo Clin Proc. 2005;80:1558-1567.
15. Garber AJ, Moghissi ES, Bransome ED Jr, et al (American College of Endocrinology Task Force on Inpatient Diabetes and Metabolic Control). American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract. 2004;10:77-82.
16. Browning LA, Dumo P. Sliding-scale insulin: an antiquated approach to glycemic control in hospitalized patients. Am J Health-Syst Pharm. 2004;61:1611-1614.
17. Chant C, Wilson G, Friedrich JO. Validation of an insulin infusion nomogram for intensive glucose control in critically ill patients. Pharmacotherapy. 2005;25:352-359.
18. Hirsch IB, Paauw DS. Diabetes management in special situations. Endocrinol Metab Clin North Am. 1997;26:631-645.
19. Zimmerman CR, Mlynarek ME, Jordan JA, Rajda CA, Horst HM. An insulin infusion protocol in critically ill cardiothoracic surgery patients. Ann Pharmacother. 2004;38:1123-1129.
20. Taylor BE, Schallom ME, Sona CS, et al. Efficacy and safety of an insulin infusion protocol in a surgical ICU. J Am Coll Surg. 2006;202:1-9.
21. Dilkhush D, Lannigan J, Pedroff T, Riddle A, Tittle M. Insulin infusion protocol for critical care units. Am J Health-Syst Pharm. 2005;62:2260-2264.
22. Markovitz LJ, Wiechmann RJ, Harris N, et al. Description and evaluation of a glycemic management protocol for patients with diabetes undergoing heart surgery. Endocr Pract. 2002;8:10-18.
23. Goldberg PA, Siegel MD, Sherwin RS, et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004;27:461-467.
24. Bland DK, Fankhanel Y, Langford E, et al. Intensive versus modified conventional control of blood glucose level in medical intensive care patients: a pilot study. Am J Crit Care. 2005;14:370-376.
25. Collier B, Diaz J Jr, Forbes R, et al. The impact of a normoglycemic management protocol on clinical outcomes in the trauma intensive care unit [with discussion]. JPEN J Parenter Enteral Nutr. 2005;29:353-359.
26. Brown G, Dodek P. Intravenous insulin nomogram improves blood glucose control in the critically ill. Crit Care Med. 2001;29:1714-1719.
27. Laver S, Preston S, Turner D, McKinstry C, Padkin A. Implementing intensive insulin therapy: development and audit of the Bath insulin protocol. Anaesth Intensive Care. 2004;32:311-316.
28. Kanji S, Singh A, Tierney M, Meggison H, Mcintyre L, Hebert PC. Standardization of intravenous insulin therapy improves the efficiency and safety of blood glucose control in critically ill adults. Intensive Care Med. 2004;30:804-810.
29. Ku SY, Sayre CA, Hirsch IB, Kelly JL. New insulin infusion protocol improves blood glucose control in hospitalized patients without increasing hypoglycemia. Jt Comm J Qual Saf. 2005;31:141-147.
30. Lien LF, Spratt SE, Woods Z, Osborne KK, Feinglos MN. Optimizing hospital use of intravenous insulin therapy: improved management of hyperglycemia and error reduction with a new nomogram. Endocr Pract. 2005;11:240-253.
31. Orford N, Stow P, Green D, Corke C. Safety and feasibility of an insulin adjustment protocol to maintain blood glucose concentrations within a narrow range in critically ill patients in an Australian level III adult intensive care unit. Crit Care Resusc. 2004;6:92-98.
32. Bode BW, Braithwaite SS, Steed DR, Davidson PC. Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy. Endocr Pract. 2004;10(Suppl 2):71-80.
33. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003;78:1471-1478.
34. Shorr AF. Endocrine issues in the ICU. Medscape. Available at: http://www.medscape.com/viewarticle/550216.
35. U.S. National Institutes of Health. Normoglycemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation (NICE-SUGAR Study). Available at: http://www.clinicaltrials.gov/ct/show/NCT00220987? order=1.
36. ACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association consensus statement on inpatient diabetes and glycemic control. Endocr Pract. 2006;12:458-468.
37. Osorio I, Arafah BM, Mayor C, Troster AI. Plasma glucose alone does not predict neurologic dysfunction in hypoglycemic nondiabetic patients. Ann Emerg Med. 1999;33:291-298.
38. New study sparks debate about benefits of intensive insulin in medical ICU. Medscape Medical News. Available at: http://www.medscape.com/viewarticle/ 538963.
39. U.S. National Institutes of Health. Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis (VISEP Trial). Available at: http://www.clinicaltrials.gov/ct/show/NCT00135473?order=1.
40. Kanji S, Buffie J, Hutton B, et al. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med. 2005;33:2778-2785.
41. Davis DA, Taylor-Vaisey A. Translating guidelines into practice: a systematic review of theoretic concepts, practical experience, and research evidence in the adoption of clinical practice guidelines. CMAJ. 1997;157:408-416.
42. Moghissi ES, Hirsch IB. Hospital management of diabetes. Endocrinol Metab Clin N Am. 2005;34:99-116.
43. Van den Berghe G. Beyond diabetes: saving lives with insulin in the ICU. Int J Obes Relat Metab Disord. 2002; 26(Suppl 3):S3-S8.
44. Levetan CS, Salas JR, Wilets IF, Zurnoff B. Impact of endocrine and diabetes team consultation on hospital length of stay for patients with diabetes. Am J Med. 1995; 99:22-28.
45. Davis ED, Harwood K, Midgett L, Mabrey M, Lien LF. Implementation of a new intravenous method on intermediate-care units in hospitalized patients. Diabetes Educ. 2005;31:818-821.
46. Vriesendorp TM, van Santen S, DeVries JH, et al. Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med. 2006;34:96-101.
47. Roman SH, Linekin PL, Stagnaro-Green A. An inpatient diabetes QI program. Jt Comm J Qual Improv. 1995;21:693-699.